Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington’s disease is a research paper published in eLife (2023). On theSindex it has a DataRank of 0.380. It has been cited 8 times, with 7 citing works in its 1-hop citation network.
Scored on demand from live citation data
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.330
From this paper's citation signal
Citation Network Contribution
0.0505
From 6 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 7 citers.
National Institute of Neurological Disorders and Stroke
Grant: NS105709
National Institute of Neurological Disorders and Stroke
Grant: NS119471
National Institute of Neurological Disorders and Stroke
Grant: NS049206
NINDS NIH HHS
Grant: R01 NS105709
NINDS NIH HHS
Grant: R01 NS119471
NINDS NIH HHS
Grant: R01 NS049206
National Institutes of Health
Grant: 5R01NS119471-02
Therapeutic potential of base editing strategies to convert CAG to CAA in Huntington's Disease
National Institutes of Health
Grant: 5R01NS105709-02
Genetic foundation for complete mutant allele-specific CRISPR in neurodegenerative diseases
CHDI Foundation
FWCI
1.04
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals